UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000044812
Receipt No. R000051178
Scientific Title Test for confirming the efficacy of an intervention program using videos for enhancing mother-infant bonding
Date of disclosure of the study information 2021/07/09
Last modified on 2022/07/10 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Test for confirming the efficacy of an intervention program using videos for enhancing mother-infant bonding
Acronym Test for confirming the efficacy of an intervention program using videos for enhancing mother-infant bonding
Scientific Title Test for confirming the efficacy of an intervention program using videos for enhancing mother-infant bonding
Scientific Title:Acronym Test for confirming the efficacy of an intervention program using videos for enhancing mother-infant bonding
Region
Japan

Condition
Condition Mother-to-infant Bonding Disorder
Classification by specialty
Nursing
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To reduce mothers' misreading of their infants' signals, a preventive intervention of mother-to-infant bonding disorder was started by asking pregnant mothers to watch videos. The study aims to confirm the efficacy of the intervention by evaluating their psychological scales assessing the postpartum mother-infant bonding and postpartum depression.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Others
Developmental phase Not applicable

Assessment
Primary outcomes X: MIBS-J scores and EPDS scores one month after childbirth; and the differences from the scores three and six months after childbirth in the intervention group.
Y: MIBS-J scores and EPDS scores one month after childbirth; and the differences from the scores three and six months after childbirth in the control group.
Differences between X and Y.
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control No treatment
Stratification NO
Dynamic allocation NO
Institution consideration Institution is not considered as adjustment factor.
Blocking YES
Concealment No need to know

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Other
Interventions/Control_1 The control group mothers are asked to fill in the questionnaires distributed during pregnancy and one, three and six months after childbirth.
Interventions/Control_2 The intervention group mothers are asked to watch infant-related videos during pregnancy and one month after childbirth. At the same time, they are asked to fill in the questionnaires distributed during pregnancy and one, three and six months after childbirth.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Female
Key inclusion criteria Women 28 or more weeks pregnant, regardless of primiparas or multiparas.
The women participating in the study are required to fully understand the adequately provided explanation concerning the study, and express the consent on their own free will.
Key exclusion criteria Those who cannot read and write in Japanese.
Target sample size 640

Research contact person
Name of lead principal investigator
1st name Kayoko
Middle name
Last name Fujita
Organization Mejiro University
Division name Department of Nursing
Zip code 3398501
Address 320 Ukiya,Iwatsuki-ku Saitama-shi Saitama,Japan
TEL 0487972131
Email ka.fujita@mejiro.ac.jp

Public contact
Name of contact person
1st name Kayoko
Middle name
Last name fujita
Organization Mejiro University
Division name Department of Nursing
Zip code 3398501
Address 320 Ukiya,Iwatsuki-ku Saitama-shi Saitama,Japan
TEL 0487972131
Homepage URL
Email ka.fujita@mejiro.ac.jp

Sponsor
Institute Mejiro University
Institute
Department

Funding Source
Organization MEXT(Japan)
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Mejiro University Medical Research ethics committe
Address 320 Ukiya,Iwatsuki-ku Saitama-shi Saitama,Japan
Tel 0487972131
Email univsyomu@mejiro.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 目白大学(埼玉県)

Other administrative information
Date of disclosure of the study information
2021 Year 07 Month 09 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2021 Year 05 Month 27 Day
Date of IRB
2021 Year 05 Month 27 Day
Anticipated trial start date
2021 Year 07 Month 09 Day
Last follow-up date
2022 Year 05 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2021 Year 07 Month 09 Day
Last modified on
2022 Year 07 Month 10 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000051178